Our analysis revealed that the top 10 histone modifications linked to DEGs in PAH patients were exclusively acetylation marks, including H3K27ac, H3K56ac, and H4K8ac, which are histone lysine residues targeted by the histone acetyltransferase EP300 (Fig. 1B). The gene discussed is EP300; the disease is pulmonary arterial hypertension.